Recently, Gyurkocza et al. reported a novel peptidyl antagonist of the interaction between Hsp90 and survivin and demonstrated that this peptide causes massive death of cancer cells but does not reduce the viability of normal cells [25,26]. The gene discussed is BIRC5; the disease is cancer.